This information was published on 2025-04-17T07:10:16 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2538575 (IR 1848501) |
| (220) |
11 Mar 2025
|
| (300) |
US, 12 Sep 2024, 98747401
|
| (511) (510) |
Class 5
Pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the gastrointestinal disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic dermatitis, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of asthma and other breathing disorders. |
| (540) | OKSFORI |
| (550) | Word |
| (730) |
Amgen Inc.
|
Find out more about publications on the About page.